JP2015504897A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504897A5 JP2015504897A5 JP2014552287A JP2014552287A JP2015504897A5 JP 2015504897 A5 JP2015504897 A5 JP 2015504897A5 JP 2014552287 A JP2014552287 A JP 2014552287A JP 2014552287 A JP2014552287 A JP 2014552287A JP 2015504897 A5 JP2015504897 A5 JP 2015504897A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- hpv
- protein
- antigen
- particle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002245 particle Substances 0.000 claims 10
- 102000036639 antigens Human genes 0.000 claims 9
- 108091007433 antigens Proteins 0.000 claims 9
- 241000701806 Human papillomavirus Species 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 241001515965 unidentified phage Species 0.000 claims 4
- 241000341655 Human papillomavirus type 16 Species 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 2
- 239000000539 dimer Substances 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261585839P | 2012-01-12 | 2012-01-12 | |
| US61/585,839 | 2012-01-12 | ||
| PCT/US2013/020960 WO2013106525A1 (en) | 2012-01-12 | 2013-01-10 | Immunogenic hpv l2-containing vlps and related compositions and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015504897A JP2015504897A (ja) | 2015-02-16 |
| JP2015504897A5 true JP2015504897A5 (enExample) | 2016-03-03 |
| JP6185932B2 JP6185932B2 (ja) | 2017-08-23 |
Family
ID=48781889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014552287A Expired - Fee Related JP6185932B2 (ja) | 2012-01-12 | 2013-01-10 | 免疫原性のｈｐｖのｌ２を含むｖｌｐ並びに関連する組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2802349B1 (enExample) |
| JP (1) | JP6185932B2 (enExample) |
| CN (1) | CN104159606A (enExample) |
| AU (1) | AU2013207962B2 (enExample) |
| BR (1) | BR112014017242A8 (enExample) |
| CA (1) | CA2861021A1 (enExample) |
| HK (1) | HK1203837A1 (enExample) |
| WO (1) | WO2013106525A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9549976B1 (en) | 2012-11-16 | 2017-01-24 | Stc.Unm | Affinity selection of Nipah and Hendra virus-related vaccine candidates from a complex random peptide library displayed on bacteriophage virus-like particles |
| EP2971010B1 (en) | 2013-03-14 | 2020-06-10 | ModernaTX, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| EP3041938A1 (en) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| EP3041934A1 (en) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Chimeric polynucleotides |
| US9943580B2 (en) | 2013-09-12 | 2018-04-17 | Stc.Unm | Malaria vaccine |
| WO2015051214A1 (en) | 2013-10-03 | 2015-04-09 | Moderna Therapeutics, Inc. | Polynucleotides encoding low density lipoprotein receptor |
| US10821167B2 (en) | 2016-02-02 | 2020-11-03 | Unm Rainforest Innovations | VLP-based vaccines for targeting Staphylococcus aureus secreted virulence factors |
| US11371059B2 (en) | 2016-05-13 | 2022-06-28 | Flash Therapeutics | Viral particle for the transfer of RNAs, especially into cells involved in immune response |
| US11421011B2 (en) | 2017-05-18 | 2022-08-23 | Modernatx, Inc. | Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof |
| CA3076631A1 (en) * | 2017-09-29 | 2019-04-04 | Deutsches Krebsforschungszentrum | Cutaneous papilloma virus vaccine |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9113809D0 (en) * | 1991-06-26 | 1991-08-14 | Cancer Res Campaign Tech | Papillomavirus l2 protein |
| GB9420146D0 (en) * | 1994-10-06 | 1994-11-23 | Cancer Res Campaign Tech | Papillomavirus vaccine |
| US7320793B2 (en) * | 2001-01-19 | 2008-01-22 | Cytos Biotechnology Ag | Molecular antigen array |
| AU2005281743A1 (en) * | 2004-08-04 | 2006-03-16 | Cytos Biotechnology Ag | Carrier conjugates of GnRH-peptides |
| WO2011100234A2 (en) * | 2010-02-09 | 2011-08-18 | Stc.Unm | Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods |
-
2013
- 2013-01-10 JP JP2014552287A patent/JP6185932B2/ja not_active Expired - Fee Related
- 2013-01-10 AU AU2013207962A patent/AU2013207962B2/en not_active Ceased
- 2013-01-10 CA CA2861021A patent/CA2861021A1/en not_active Abandoned
- 2013-01-10 CN CN201380012267.6A patent/CN104159606A/zh active Pending
- 2013-01-10 EP EP13736349.5A patent/EP2802349B1/en active Active
- 2013-01-10 HK HK15104584.7A patent/HK1203837A1/xx unknown
- 2013-01-10 WO PCT/US2013/020960 patent/WO2013106525A1/en not_active Ceased
- 2013-01-10 BR BR112014017242A patent/BR112014017242A8/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504897A5 (enExample) | ||
| Jain et al. | Formulation and stabilization of recombinant protein based virus-like particle vaccines | |
| JP2016155867A5 (enExample) | ||
| JP2012010713A5 (enExample) | ||
| TR201908199T4 (tr) | HPV'ye karşı aşılar. | |
| SG131116A1 (en) | Functional influenza virus-like particles (vlps) | |
| JP2014502156A5 (enExample) | ||
| WO2020163719A3 (en) | Nanoparticle-based influenza virus vaccines and uses thereof | |
| MX376568B (es) | Vacunas mejoradas para el virus del papiloma humano y métodos para utilizarlas. | |
| EP3199545A3 (en) | Computationally optimized broadly reactive antigens for h1n1 influenza | |
| SG10201903538YA (en) | Modified virus-like particles of cmv | |
| NZ595710A (en) | Recombinant virus-like particles encoded by multi-gene vector | |
| JP2015524422A5 (enExample) | ||
| HK1208355A1 (en) | Universal influenza vaccine based on heterologous multiple m2e proteins | |
| NZ741875A (en) | Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof | |
| JP2006512413A5 (enExample) | ||
| JOP20220187A1 (ar) | لقاح فيروس الورم الحليمي البشري (hpv) | |
| JP2010506926A5 (enExample) | ||
| JP2013541528A5 (enExample) | ||
| MY197457A (en) | Chimeric papillomavirus l1 protein | |
| Sharma et al. | A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancer | |
| EA033242B1 (ru) | Усовершенствованные нуклеиновые кислоты и белки вируса человеческой папилломы, вакцины и композиции на их основе и способы индукции иммунного ответа против впч с их применением | |
| MX2019007924A (es) | Vacunas contra la influenza. | |
| WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
| WO2008082719A3 (en) | Combined human papillomavirus vlp/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors |